Calendar of Events
S Sun
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
2 events,
Third International Summit on Human Genome Editing
The Third International Summit on Human Genome Editing will take place on 6-8 March 2023 at the Francis Crick Institute, London UK. Building on previous events held in Washington, D.C. (2015) and Hong Kong (2018), this Summit will continue the important dialogue around human genome editing. It will facilitate a global discussion on somatic and germline genome editing, including developments in clinical trials and genome editing tools such as CRISPR/Cas9. Earlier this year a three-part series of online events Looking Ahead to the Third Human Genome Editing Summit discussed some of the key topics of the meeting.
The three-day summit is being organized by the Royal Society, the UK Academy of Medical Sciences, the US National Academies of Sciences and Medicine and The World Academy of Sciences.
Molecular & Precision Med TRI-CON 2023
For almost 3 decades, the Molecular & Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. As we celebrate the 30th Anniversary and look forward to in-person networking, Cambridge Healthtech Institute once again takes the leadership role of bringing together the life science community at the TRI-CON 2023. Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including Multi-Cancer Early Detection and Minimal Residual Disease testing; and emerging technologies for spatial biology and single-cell multiomics. The new track on Digital Medicine reflects the future of precision medicine and adds coverage of artificial intelligence, digital diagnostics and digital biomarkers, digital pathology, sensors and wearables. Join us in sunny San Diego for the in-person networking you’ve come to expect from the TRI-CON and special 30th Anniversary keynotes. Don’t miss a minute of the cutting-edge 10-track scientific program with convenient on-demand viewing.
0 events,
0 events,
0 events,
0 events,
1 event,
Bioprocessing Summit Europe
The Bioprocessing Summit Europe brings together 500+ bioproduction, analytical and formulation professionals to advance the manufacture, quality and control of biological and genetic therapies. This 3-day, 10 track meeting has quickly become a premier meeting in the European bioprocessing calendar and is regarded by many as “the fastest growing bioprocessing meeting in Europe” following record growth in 2022 – 350 to 500+ attendees - and a sold out Exhibit Hall.
We look forward to seeing you in Barcelona, or online, 14-16 March 2023, with expanded content on cell and gene therapy CMC and manufacturing, educational training seminars and a vastly bigger Exhibit Hall.
1 event,
1 event,
1 event,
0 events,
2 events,
RNA and DNA Editing and Epitranscriptomics Across Biological Systems
The RNA Editing GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Cell Symposium: Viruses in health and disease
This meeting will bring together research that encompasses basic and translational virology. We envision this meeting showcasing the ubiquity of viruses while highlighting commonalities among researchers, from technology through a standard goal of understanding how viruses behave and adapt and how this may be exploited for prediction of the next outbreak or leveraged for therapeutic development.
The scientific response to SARS-CoV-2/COVID-19 continues to showcase how science has progressed, as the rapidity of basic and translational research has been second to none, while also revealing our weaknesses as a population. This meeting is both a celebration of how far virology has come and a forecast of what is next and the inroads to get us there.
Our topics will include:
1) Viruses within: defining the virome; interaction with the microbiome; endogenous retroviruses in health and disease; tools and technologies
2) Viral pathogens: evolution, genomics, spread, prediction, and pandemic preparedness of emerging and re-emerging viruses
3) Virus-host interaction: immunology, genetics, and host factors
4) Viruses as therapeutics: diagnostics, phage therapy, viral vectors, and disease therapy
5) Targeting viruses: antivirals, vaccines, antibodies: lessons from the past; successes versus failures
4 events,
6th Annual Gene Therapy for Rare Disorders 2023 Summit
As the gene therapy field continues to break records, there are still significant challenges to overcome relating to safety, efficacy, and accessibility. The 6th Annual Gene Therapy for Rare Disorders 2023 Summit remains devoted to showcasing the top case studies and strategic learnings from the past year. With an expert speaking faculty devoted to bringing safer and more effective gene therapies to rare disease patients, key questions will be answered on how best the field can overcome regulatory, clinical, manufacturing and pricing bottlenecks to progress gene therapies into and through the clinic.